News

Edward Costello Joins meQuilibrium as Chief Revenue Officer

Edward Costello Joins meQuilibrium as Chief Revenue Officer

Edward Costello Takes on Chief Revenue Officer Role at meQuilibrium

Costello Brings Unique Combination of Human Capital, Wellness and Sales Experience to meQ

meQuilibrium (meQ), the world's leading workforce resilience expert, today announced that Edward Costello has joined the senior management team as chief revenue officer (CRO). Costello will lead meQ's sales and revenue growth opportunities, including client success, partner management, new revenue channels, and pricing strategy. His impressive background includes serving as a strategic advisor to Fortune 500 HR companies at Mercer, and building a direct-to-employer testing and wellness services business at Labcorp.

Complementing the Executive Leadership Team

CEO and co-founder, Jan Bruce, expressed enthusiasm about Costello's appointment, stating, "We are delighted that Ed is joining our executive leadership team. His deep customer-centric experience with HR and healthcare buyers, along with his strategic understanding of their evolving needs, are a strong complement to meQ's leadership team." Bruce believes Costello is uniquely positioned to lead meQ's commercial operations, delivering valuable solutions to leading employers today.

Proven Success in the Industry

During his long tenure with Mercer, a global leader in shaping the future of work and enhancing health outcomes, Costello held various leadership and consulting roles that enabled him to develop commercial strategies and oversee key global client relationships. His insights into customer needs will be instrumental as he shapes meQ's sales approach.

Driving Positive Change in Workforce Health

Most recently, Costello led Labcorp's Employer Services, a diagnostic testing and wellness services unit that positively impacted more than 10 million lives annually through a dedicated workforce of over 5,000 part-time colleagues. According to Brad Kimler, a meQuilibrium Board Member, "Ed is a proven business leader with a remarkable track record in HR and healthcare. His deep understanding of workforce issues will help expand the ways meQ drives meaningful improvements in health and well-being across diverse organizations.”

Vision for the Future

Costello expressed his excitement about joining the meQ team, stating, "I am excited to join the meQ team, helping organizations drive human performance and better manage the hidden risks in their workforce. Our approach goes beyond traditional benefits, focusing on skill building–helping employees navigate change, overcome challenges, increase agility, and enhance their adaptive capacities, leading to a direct, positive impact on business performance." This forward-thinking mindset aligns perfectly with meQ’s mission to foster healthy and productive workforces.

A Bright Academic Background

Edward Costello is a proud alumnus of Bucknell University, where he laid the foundations for his successful career. He earned his MBA at Northwestern University's prestigious Kellogg School of Management. Although based in Charlotte, North Carolina, his influence and contributions are expected to resonate on a global scale as meQuilibrium continues its mission.

About meQuilibrium

meQuilibrium, the world's leading workforce resilience expert, identifies, addresses, and measures the root causes of risks to workforce performance, engagement, and well-being. By utilizing a data analytics-based approach that leverages artificial intelligence, meQ predicts workforce risks and personalizes solutions for employees and teams worldwide. Their mission is to transform any workforce into a force for growth, with services available in 17 languages across over 130 countries.

Frequently Asked Questions

What is Edward Costello's role at meQuilibrium?

Edward Costello has been appointed as the Chief Revenue Officer, focusing on driving sales and revenue growth.

What previous experience does Costello bring to meQuilibrium?

Costello has extensive experience in HR consulting with Mercer and led Labcorp's Employer Services, impacting millions of lives.

What is meQuilibrium known for?

meQuilibrium is recognized as a leader in workforce resilience, using data analytics to enhance employee engagement and well-being.

How does meQuilibrium personalize its solutions?

Through AI analytics, meQ predicts workforce risks and customizes solutions to fit individual employee needs.

In how many languages does meQuilibrium operate?

meQuilibrium offers its solutions in 17 languages, making it accessible to a global workforce.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Hyzon Motors Plans Delisting from Nasdaq—What This Means

Updated Category News Views 195

Hyzon Motors Announces Delisting from Nasdaq Hyzon Motors Inc. is making a significant shift regarding its stock trading status. This U.S. company, known for its commitment to high-performance hydrogen fuel cell technology, has decided to inform Nasdaq Stock Market of its intent to delist its Class A common stock and publicly traded warrants. This move comes as part of...

Continue Reading
Unlock the Potential of Crypto Staking with Keynode.net

Updated Category News Views 113

Your Gateway to High Returns in Crypto Staking As the digital currency landscape continues to expand, platforms like Keynode.net are leading the charge in offering unprecedented opportunities for investors. For those seeking impressive annual percentage yields (APY) through crypto staking, Keynode.net has emerged as a premier choice. Its user-friendly interface, robust...

Continue Reading
Critical Updates for Rocket Pharmaceuticals Investors Amid Lawsuit

Updated Category News Views 263

Overview of the Class Action Lawsuit Against Rocket Pharmaceuticals Pomerantz LLP has initiated a class action lawsuit against Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) highlighting various concerns regarding the company's business practices. Investors who have suffered losses during the stipulated Class Period should take note of this unfolding situation. Key Details...

Continue Reading
Revitalizing Economic Growth at the 23rd SMDO Conference

Updated Category News Views 141

Revitalizing Economic Growth at the 23rd SMDO Conference The 23rd Annual South Metro Development Outlook (SMDO25) Conference stands as a pivotal forum for industry leaders, policymakers, and community stakeholders. It is designed to foster collaboration and tackle some of the most pressing issues faced by the region today. Set against the backdrop of changing federal...

Continue Reading
SciBase's Strong Growth in Q1 2025: Key Highlights and Future

Updated Category News Views 222

Strong First Quarter Results for SciBase In the recent interim report, SciBase has showcased an impressive performance for the first quarter of 2025. The medical technology company, renowned for its innovative dermatological solutions, recorded net sales of TSEK 8,856, marking a remarkable increase of 46% from the previous year’s figures. Financial Performance Overview...

Continue Reading